EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME

by A. V. Rudakova, N. V. Lomakin
Published 2015-09-01

EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME

by A. V. Rudakova, N. V. Lomakin
Published 2015-09-01

Thrombocytopenia and prospective endovascular intervention in a patient with coronary artery disease

by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
Published 2019-01-01

Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding

by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
Published 2019-01-01

A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Di...

by N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey
Published 2020-07-01

Effect of lornoxicam on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome

by Nikita Valer'evich Lomakin, Aleksey Kirillovich Gruzdev, N V Lomakin, A K Gruzdev
Published 2010-12-01

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients

by A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin
Published 2020-03-01